Emfo, LLC Clovis Oncology, Inc. Transaction History

Emfo, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$1.05 - $2.85 $2,100 - $5,700	-2,000 Reduced 11.11%	16,000 $19,000
Q2 2022 Jul 27, 2022	SELL	$0.63 - $2.96 $2,205 - $10,360	-3,500 Reduced 16.28%	18,000 $32,000
Q4 2021 Jan 27, 2022	SELL	$2.7 - $4.76 $64,800 - $114,240	-24,000 Reduced 52.75%	21,500 $58,000
Q2 2021 Jul 20, 2021	BUY	$5.02 - $7.05 $228,409 - $320,775	45,500 New	45,500 $264,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Emfo, LLC, based on Form 13F filings with the SEC.

Stay updated on Emfo, LLC with notifications on news.